|
Volumn 90, Issue 3, 1999, Pages 882-889
|
FDA's role, in anesthetic drug development
|
Author keywords
Clinical trials; Federal regulations; IND; NDA; Pharmaceutical industry
|
Indexed keywords
ANESTHETIC AGENT;
BUPIVACAINE;
CLONIDINE;
KETAMINE;
KETOROLAC;
METOCLOPRAMIDE;
MIDAZOLAM;
MORPHINE;
NEOSTIGMINE;
ONDANSETRON;
PETHIDINE;
SALBUTAMOL;
SUFENTANIL;
ANESTHESIA;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG DEVELOPMENT;
DRUG POTENCY;
FOOD AND DRUG ADMINISTRATION;
INFORMED CONSENT;
LAW;
MEDICAL DOCUMENTATION;
ORGANIZATION;
PEDIATRICS;
POPULATION RESEARCH;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
REVIEW;
|
EID: 0032940765
PISSN: 00033022
EISSN: None
Source Type: Journal
DOI: 10.1097/00000542-199903000-00032 Document Type: Review |
Times cited : (3)
|
References (13)
|